Search Results - "Saavedra, Alene A"

Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis by Zhang, Qianru, McDermott, Gregory C, Juge, Pierre-Antoine, Chang, Sung Hae, Vanni, Kathleen MM, Qian, Grace, Bade, Katarina J, Mueller, Kevin T, Kowalski, Emily N, Saavedra, Alene A, Sparks, Jeffrey A

“…To investigate the association of disease-modifying antirheumatic drugs (DMARDs) and risk of incident interstitial lung disease (ILD) among patients with…”
Get full text

Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease by Venkat, Rathnam K., Hayashi, Keigo, Juge, Pierre-Antoine, McDermott, Gregory, Paudel, Misti, Wang, Xiaosong, Vanni, Kathleen M. M., Kowalski, Emily N., Qian, Grace, Bade, Katarina J., Saavedra, Alene A., Mueller, Kevin T., Chang, Sung Hae, Dellaripa, Paul F., Weinblatt, Michael E., Shadick, Nancy A., Doyle, Tracy J., Dieude, Philippe, Sparks, Jeffrey A.

“…We aimed to determine the prevalence and outcomes for forced vital capacity percent predicted (FVCpp) decline among patients with rheumatoid…”
Get full text

Treatment of rheumatoid arthritis-associated interstitial lung disease: An appraisal of the 2023 ACR/CHEST guideline by Saavedra, Alene A., Mueller, Kevin T., Kowalski, Emily N., Qian, Grace, Bade, Katarina J., Vanni, Kathleen M. M., McDermott, Gregory C., Sparks, Jeffrey A.

“…Purpose of Review To summarize the current treatment landscape of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) in the context of the…”
Get full text